|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0004238,
umls-concept:C0008976,
umls-concept:C0018801,
umls-concept:C0026565,
umls-concept:C0030705,
umls-concept:C0035647,
umls-concept:C0205217,
umls-concept:C0231220,
umls-concept:C0231221,
umls-concept:C0242698,
umls-concept:C0332281,
umls-concept:C0449258,
umls-concept:C0936012,
umls-concept:C1277187,
umls-concept:C1514923,
umls-concept:C2603343
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1998-9-28
|
|
pubmed:abstractText |
This study undertook to determine if the presence of atrial fibrillation in patients with asymptomatic and symptomatic left ventricular dysfunction was associated with increased mortality and, if so, whether the increase could be attributed to progressive heart failure or arrhythmic death.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0735-1097
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
32
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
695-703
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9741514-Adult,
pubmed-meshheading:9741514-Aged,
pubmed-meshheading:9741514-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:9741514-Atrial Fibrillation,
pubmed-meshheading:9741514-Cause of Death,
pubmed-meshheading:9741514-Dose-Response Relationship, Drug,
pubmed-meshheading:9741514-Double-Blind Method,
pubmed-meshheading:9741514-Enalapril,
pubmed-meshheading:9741514-Female,
pubmed-meshheading:9741514-Heart Failure,
pubmed-meshheading:9741514-Hemodynamics,
pubmed-meshheading:9741514-Humans,
pubmed-meshheading:9741514-Male,
pubmed-meshheading:9741514-Middle Aged,
pubmed-meshheading:9741514-Retrospective Studies,
pubmed-meshheading:9741514-Risk,
pubmed-meshheading:9741514-Survival Rate,
pubmed-meshheading:9741514-Systole,
pubmed-meshheading:9741514-Ventricular Dysfunction, Left
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction.
|
|
pubmed:affiliation |
Clinical Trials Scientific Research Group, The National Heart, Lung and Blood Institute, Bethesda, Maryland 20892, USA. Ddries@aol.com
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|
